Quantum Biopharma Ltd. submitted a Form 6-K on September 29, 2025, signaling compliance under the Securities Exchange Act of 1934. The report includes an authorization signature from CFO Donal Carroll.
AI Assistant
QUANTUM BIOPHARMA LTD
2025
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.